Literature DB >> 10787033

Retrospective study of Creutzfeldt-Jakob disease in Belgium: neuropathological findings.

B Van Everbroeck1, P Pals, T Dziedzic, R Dom, C Godfraind, R Sciot, J M Brucher, J J Martin, P Cras.   

Abstract

Creutzfeldt-Jakob disease (CJD) is a spongiform encephalopathy that affects about 1 in 10(6) inhabitants in most countries. Recently, a new variant of CJD has been linked to the epidemic of bovine spongiform encephalopathy. Therefore, vigilance concerning the disease's incidence has been increased. We conducted a comprehensive, nation-wide and retrospective study. In 79 Belgian autopsies, we found the characteristic triad of spongiosis, neuronal loss and reactive gliosis. The occipital cortex was most affected, while the cerebellum was mostly spared. Immunohistochemistry was performed using hydrated autoclave pretreatment and several monoclonal antibodies directed against the prion protein. We identified prion-immunoreactive patterns and locations reflecting the important heterogeneity, independently of the antibody that was used. Granular prion immunoreactivity was observed in astrocytes. We studied the regional intensity of the prion immunostaining and determined that the frontal cortex with 95% positive immunoreactivity was best suited for a biopsy. We studied the disease duration in sporadic CJD patients who showed neuropathological lesions of other neurodegenerative disorders (such as Alzheimer's disease). The study shapes the framework in which a prospective neuropathological registry will be able to function.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10787033     DOI: 10.1007/s004010051136

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  5 in total

1.  Analysis of the exon 1 polymorphism in the Tau gene in transmissible spongiform encephalopathies.

Authors:  Raquel Sánchez-Valle; Pau Pastor; Jordi Yagüe; Teresa Ribalta; Francesc Graus; Eduardo Tolosa; Albert Saiz
Journal:  J Neurol       Date:  2002-07       Impact factor: 4.849

2.  Increased incidence of sporadic Creutzfeldt-Jakob disease in the age groups between 70 and 90 years in Belgium.

Authors:  B Van Everbroeck; A Michotte; R Sciot; C Godfraind; M Deprez; S Quoilin; J-J Martin; P Cras
Journal:  Eur J Epidemiol       Date:  2006-07-12       Impact factor: 8.082

3.  Diffusion-weighted MRI findings and clinical correlations in sporadic Creutzfeldt-Jakob disease.

Authors:  Ting Gao; Jin-Hao Lyu; Jia-Tang Zhang; Xin Lou; Wei Zhao; Xiao-Wei Xing; Ming Yang; Yan Yao; Qing-Che Tan; Cheng-Lin Tian; Xu-Sheng Huang; Lin Ma; Sheng-Yuan Yu
Journal:  J Neurol       Date:  2015-04-11       Impact factor: 4.849

4.  A prospective study of CSF markers in 250 patients with possible Creutzfeldt-Jakob disease.

Authors:  B Van Everbroeck; S Quoilin; J Boons; J J Martin; P Cras
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-09       Impact factor: 10.154

5.  Classification of sporadic Creutzfeldt-Jakob disease based on clinical and neuropathological characteristics.

Authors:  José Cortiñas Abrahantes; Marc Aerts; Bart van Everbroeck; Claude Saegerman; Dirk Berkvens; Helena Geys; Koen Mintiens; Stefan Roels; Patrick Cras
Journal:  Eur J Epidemiol       Date:  2007-06-21       Impact factor: 8.082

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.